Effects zymosan-activated human granulocytes isolated human airways asthma temporal association late allergic reaction LAR influx granulocytes airway wall increase bronchial responsiveness hypothesis human granulocytes human airways sensitivity stimuli Bronchial rings lung tissue thoracotomy organ baths Airways granulocytes normal atopic donors Activation cells serum-treated zymosan STZ mg/ml baseline airway caliber bronchoconstriction proportional number zymosan-activated granulocytes ZAG present rs contraction leukotriene receptor antagonist FPL microM lipoxygenase inhibitor nordihydroguaiaretic acid microM scavengers activated oxygen molecules dismutase U/ml bovine catalase U/ml cyclooxygenase inhibitor indomethacin microM histamine receptor antagonist mepyramine microM effect Granulocyte suspensions atopic donors eosinophils magnitude contraction ZAG proportion eosinophils sensitivity airways unchanged presence ZAG ZAG 